sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
SEPN
Updated 10/6/2026, 1:28 PM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| SEPN Septerna, Inc. | Sale | $126,078 | Long Daniel D. SVP, Drug Discovery | 3,333 sh | at $37.83 | Filed Sep 3, 7:01 PM ET | Filing | |
| SEPN Septerna, Inc. | Sale | $7,399,858 | Third Rock Ventures V, L.P. 10% owner and 5 others | 147,200 sh | at $50.27 | Filed Aug 14, 5:44 PM ET | Filing | |
| SEPN Septerna, Inc. | Sale | $63,452,500 | RA CAPITAL MANAGEMENT, L.P. Director, 10% owner and 4 others | 1,493,000 sh | at $42.50 | Filed Aug 14, 5:11 PM ET | Filing | |
| SEPN Septerna, Inc. | Sale | $1,100,000 | Bhatt Elizabeth President and COO | 25,000 sh | at $44.00 | Filed Aug 13, 7:00 PM ET | Filing | |
| SEPN Septerna, Inc. | Sale | $114,920 | Long Daniel D. SVP, Drug Discovery | 3,334 sh | at $34.47 | Filed Aug 5, 7:00 PM ET | Filing | |
| SEPN Septerna, Inc. | Sale | $135,974 | Bhatt Elizabeth President and COO | 4,000 sh | at $33.99 | Filed Jul 17, 7:00 PM ET | Filing |